Best Practices For Reducing Variability Without Increasing Regulatory Burden
Source: Entegris, Inc.
Donna Rill, Chief Technology Officer at Triumvira Immunologics, shares why expectations grow along the curve and why understanding what's expected early on is important. She shared the Agency is amicable to less tight specifications of your release testing and much more.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Entegris, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more